WHO ICTRP trial
Investigating the effect of citicoline administration on cognitive impairment…
IRCT20241029063537N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20241029063537N2 |
|---|---|
| Public title | Investigating the effect of citicoline administration on cognitive impairment, social interactions, and speech status in autistic children A clinical trial study |
| Scientific title | Investigating the effect of citicoline administration on cognitive impairment, social interactions, and speech status in autistic children at pre-school and post-school ages |
| Primary sponsor | Semnan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 4 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Autism. Autistic disorder;F84.0 |
| Interventions | Intervention 1: Intervention group: In the intervention group, the drug citicoline cytidine-5'-diphosphocholine (CDP-choline) will be administered for 5 weeks in addition to the usual treatment for autism (occupational therapy, speech… |
| Registration date | Jun 12, 2025 |
| Target size | 80 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: